NCT04334941 2026-04-13Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive BiomarkerNational Cancer Institute (NCI)Phase 2 Active not recruiting103 enrolled
NCT05142241 2025-11-18Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting14 enrolled